Haptoglobin polymorphism: A key factor in the proatherogenic role of B cells?

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 80-82

  Delanghe, Joris R ^a   Langlois, Michel R ^a,b   De Buyzere, Marc L ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Atherosclerosis; B lymphocytes; CD163; CD22; Haptoglobin

Indexed keywords

APOLIPOPROTEIN A1; AUTOANTIBODY; CD11B ANTIGEN; CD18 ANTIGEN; CD22 ANTIGEN; CHEMOATTRACTANT; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN; SCLEROPROTEIN;

ANTIBODY PRODUCTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; B LYMPHOCYTE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; LYMPHOCYTE; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MAST CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN POLYMORPHISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD22; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATHEROSCLEROSIS; AUTOANTIBODIES; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; HAPTOGLOBINS; HEMOLYSIS; HUMANS; LIPOPROTEINS, LDL; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE;

EID: 79960279316     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.031     Document Type: Article

References (22)

1. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
2. Nilsson J., Fredrikson G.N. The B cell in atherosclerosis: teaming up with the bad guys?. Clin Chem 2010, 56:1789-1791.
3. Ait-Oufella H., Herbin O., Bouaziz J.D., et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010, 207:1579-1587.
4. Kyaw T., Tay C., Khan A., et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010, 185:4410-4419.
5. Hanasaki K., Powell L.D., Varki A. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin. J Biol Chem 1995, 270:7543-7550.
6. Nitschke L. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol Rev 2009, 230:128-143.
7. Lajaunas F., Nitschke L., Moll T., et al. Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes. J Immunol 2002, 168:6078-6083.
8. Langlois M., Delanghe J. Biological and clinical significance of haptoglobin polymorphism in man. Clin Chem 1996, 42:1589-1600.
9. Levy A.P., Roguin A., Hochberg I., Herer P., Marsh S., Nakhoul F.M., Skorecki K. Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 2000, 343:969-970.
10. Langlois M., Delanghe J., Philippé J., et al. Distribution of lymphocyte subsets in bone marrow and peripheral blood is associated with haptoglobin type. Binding of haptoglobin to the B-cell lectin CD22. Eur J Clin Chem Clin Biochem 1997, 35:199-205.
11. Arredouani M., Matthijs P., Van Hoeyveld E., et al. Haptoglobin directly affects T cells and suppresses T helper type 2 cytokine release. Immunology 2003, 108:144-151.
12. Robertson A.-K., Hansson G.K. T cells in atherosclerosis. For better or for worse?. Arterioscler Thromb Vasc Biol 2006, 26:2421-2432.
13. Brouwers A., Langlois M., Delanghe J., et al. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 2004, 176:189-195.
14. Langlois M.R., Martin M.-E., Boelaert J.R., et al. The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clin Chem 2000, 46:1619-1625.
15. Levy A.P., Levy J.E., Kalet-Litman S., et al. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 2007, 27:134-140.
16. Guetta J., Strauss M., Levy N.S., Fahoum L., Levy A.P. Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis 2007, 191:48-53.
17. Xie Y., Li Y., Zhang Q., Stiller M.J., Albert Wang C.-L., Wayne Streilein J. Haptoglobin is a natural regulator of Langerhans cell function in the skin. J Dermatol Sci 2000, 24:25-73.
18. Wagner L., Gessl A., Baumgartner Parzer S., Base W., Waldhäusl W., Pasternack M.S. Haptoglobin phenotyping by newly developed monoclonal antibodies. Demonstration of haptoglobin uptake into peripheral blood neutrophils and monocytes. J Immunol 1996, 156:1989-1996.
19. El Ghmati S.M., Van Hoeyveld E.M., Van Strijp J.A.G., Ceuppens J.L., Stevens E.A.M. Identification of haptoglobin as an alternative ligand for CD11b/CD18. J Immunol 1996, 156:2542-2552.
20. El Ghmati S.M., Arredouani M., Van Hoeyveld E.M., Ceuppens J.L., Stevens E.A. Haptoglobin interacts with the human mast cell line HMC-1 and inhibits its spontaneous proliferation. Scand J Immunol 2002, 55:352-358.
21. Watanabe J., Grijalva V., Hama S., et al. Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein. J Biol Chem 2009, 284:18292-18301.
22. Maffei M., Funicello M., Vottari T., et al. The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2). BMC Biol 2009, 7:87.